NASDAQ:MGRX Mangoceuticals (MGRX) Stock Price, News & Analysis $0.28 -0.01 (-3.49%) (As of 12/29/2023 ET) Add Compare Share Share Today's Range$0.27▼$0.3050-Day Range$0.27▼$0.9652-Week Range$0.27▼$4.37Volume395,362 shsAverage Volume574,643 shsMarket Capitalization$4.82 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media About Mangoceuticals Stock (NASDAQ:MGRX)Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. The company provides erectile dysfunction and hair growth products under the Mango and Mango GROW brand names. It sells its products through its online website at mangorx.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.Read More MGRX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MGRX Stock News HeadlinesDecember 15, 2023 | finance.yahoo.comMangoceuticals, Inc. Announces Pricing of $1,200,000 Public OfferingDecember 15, 2023 | investorplace.comWhy Is Mangoceuticals (MGRX) Stock Down 33% Today?December 31, 2023 | Behind the Markets (Ad)New Year's Sale: Get 12 Months of Stock Picks for $9.00Gear up for what's happening in the stock market in 2024. Our friends at Behind the Markets are offering an opportunity that is simply too good to pass up - 12-months of their best stock ideas for just $9.00. Don't sleep on this. December 13, 2023 | finance.yahoo.comMANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCTDecember 12, 2023 | msn.comMangoceuticals files to sell 5M shares of common stockDecember 6, 2023 | finance.yahoo.comMangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin AmericaDecember 5, 2023 | theglobeandmail.comMangoceuticals ($MGRX) Pioneering the Future of Men’s Health with Innovative Products and Strategic PartnershipsNovember 16, 2023 | finance.yahoo.comMangoceuticals Expands its Men's Health Product Line with Compounded Hair Growth Treatment 'Grow' by MangoRxDecember 31, 2023 | Behind the Markets (Ad)New Year's Sale: Get 12 Months of Stock Picks for $9.00Gear up for what's happening in the stock market in 2024. Our friends at Behind the Markets are offering an opportunity that is simply too good to pass up - 12-months of their best stock ideas for just $9.00. Don't sleep on this. November 2, 2023 | finance.yahoo.comMangoceuticals, Inc. Launches Charitable Initiative in Support of Men’s Health Awareness MonthOctober 26, 2023 | finance.yahoo.comMangoceuticals Launches TikTok Influencer Initiative and Becomes the Presenting Sponsor of the Only Stans Podcast with Glenny BallsOctober 19, 2023 | finance.yahoo.comMangoceuticals, Inc. Provides Update to Shareholders on Q3 Achievements and Guidance on Year End and Near-Term InitiativesOctober 13, 2023 | finance.yahoo.comMangoceuticals Announces TV Air Dates for Interview Featuring CEO Jacob Cohen on Bloomberg TV and Fox BusinessOctober 12, 2023 | finance.yahoo.comMangoceuticals Announces the Official Launch of MangoRx Affiliate Marketing Program to Enhance and Accelerate Topline GrowthSeptember 14, 2023 | finance.yahoo.comMangoceuticals Brand MangoRx Announced as Raindance Film Festival’s Headline SponsorSeptember 7, 2023 | finance.yahoo.comMangoceuticals Expands its Nationwide Marketing Efforts with a Multiplatform Audio Powerhouse Across AmericaAugust 30, 2023 | finance.yahoo.comMangoceuticals Launches New High-Production Quality Ad Providing Fresh Insight into its Proprietary Mango Erectile Dysfunction Pill FormulaAugust 16, 2023 | finance.yahoo.comMangoceuticals Launches New Sildenafil Based Erectile Dysfunction Product with Signature Mango Flavor & Rapid DissolveAugust 9, 2023 | finance.yahoo.comMangoceuticals Partners with Greater NY Chamber of Commerce for Mass Marketing & Sales of Flagship Mango ProductAugust 2, 2023 | finance.yahoo.comMangoceuticals, Inc. Names Award Winning Globally Recognized Lucky Break PR as Public Relations FirmAugust 1, 2023 | finance.yahoo.comMangoceuticals Engages Premier Global Software Development Firm, RedLime Solutions to Expand Technology Platform to Accommodate Increased Customer FlowJuly 27, 2023 | finance.yahoo.comMangoceuticals, Inc. Adds Top Men’s Podcast, Pillow Talk with Ryan Pownall, to Sponsorship PortfolioJuly 27, 2023 | benzinga.comMangoceuticals (MGRX) Presents A Golden Opportunity Amid Exciting Partnerships and Dynamic Marketing StrategiesJuly 24, 2023 | finance.yahoo.comNew to The Street TV Announces Episode 491 with its Five Business Guest Interviews, Airs on FOX Business Network, Tonight, July 24, 2023, at 10:30 PM PTJuly 18, 2023 | finance.yahoo.comMangoceuticals Engaged by Social Media Sensation Adam22 as Exclusive New Sponsor of Hit Podcasts with Skyrocketing Male EngagementJuly 13, 2023 | benzinga.comMangoceuticals (NASDAQ:MGRX) Revolutionizing Men's Health and Positioned for Robust GrowthJuly 12, 2023 | benzinga.comMangoceuticals (NASDAQ:MGRX) in focus as Wall Street narrows focus on major inflation reportSee More Headlines Receive MGRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mangoceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/27/2023Today12/31/2023Fiscal Year End12/31/2023Next Earnings (Estimated)1/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MGRX CUSIPN/A CIK1938046 Webwww.mangorx.com Phone833-626-4679FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,000,000.00 Net Margins-1,472.66% Pretax Margin-1,472.46% Return on Equity-332.08% Return on Assets-291.61% Debt Debt-to-Equity RatioN/A Current Ratio8.44 Quick Ratio8.30 Sales & Book Value Annual Sales$10,000.00 Price / Sales482.36 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares17,420,000Free FloatN/AMarket Cap$4.82 million OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Jacob D. Cohen (Age 44)CEO & Chairman Comp: $70kMr. Jonathan Arango (Age 28)President, Secretary & Director Comp: $50kMr. Eugene M. Johnston (Age 59)Chief Financial Officer Ms. Amanda Elizabeth Hammer (Age 38)Chief Operating Officer Key CompetitorsBioRestorative TherapiesNASDAQ:BRTXGreenbrook TMSNASDAQ:GBNHOntrakNASDAQ:OTRKExicureNASDAQ:XCURNemaura MedicalNASDAQ:NMRDView All CompetitorsInsidersJacob D CohenBought 275,000 shares on 4/10/2023Total: $275,000.00 ($1.00/share)View All Insider Transactions MGRX Stock Analysis - Frequently Asked Questions How have MGRX shares performed in 2023? Mangoceuticals' stock was trading at $3.05 at the beginning of the year. Since then, MGRX stock has decreased by 90.9% and is now trading at $0.2769. View the best growth stocks for 2023 here. When is Mangoceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, January 26th 2024. View our MGRX earnings forecast. How were Mangoceuticals' earnings last quarter? Mangoceuticals, Inc. (NASDAQ:MGRX) announced its quarterly earnings results on Friday, October, 27th. The company reported ($0.11) EPS for the quarter. The firm had revenue of $0.25 million for the quarter. Mangoceuticals had a negative trailing twelve-month return on equity of 332.08% and a negative net margin of 1,472.66%. When did Mangoceuticals IPO? (MGRX) raised $5 million in an initial public offering on Tuesday, March 21st 2023. The company issued 1,300,000 shares at a price of $4.00 per share. Boustead Securities served as the underwriter for the IPO. How do I buy shares of Mangoceuticals? Shares of MGRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MGRX) was last updated on 12/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.